| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |